Health
FDA Approves Sunharbo to Cut Recurrent Stroke Risk
A new FDA-approved stroke-prevention pill cut ischemic stroke risk by 26% in a 12,327-person trial, but its use is limited to specific patients.
shahzad · · 7 min read
2 results for "stroke prevention"
A new FDA-approved stroke-prevention pill cut ischemic stroke risk by 26% in a 12,327-person trial, but its use is limited to specific patients.
shahzad · · 7 min read
A trial in adults 70+ met its two-year noninferiority threshold, but the group that stopped statins had more cardiovascular events.
shahzad · · 8 min read